The Framework Convention on Tobacco Control

Vincent T DeVita Jr

doi:10.1038/ncponc0133 | Full Text | PDF (48K)

The role of preoperative chemotherapy for esophageal cancer: when is surgery alone feasible?

Geoff Chong and David Cunningham

doi:10.1038/ncponc0126 | Full Text | PDF (69K)

How do we care for patients with malignant glioma?

doi:10.1038/ncponc0141 | Full Text | PDF (63K)

Predicting recurrence in patients with breast cancer

doi:10.1038/ncponc0143 | Full Text | PDF (57K)

Advances in immunotherapy for chronic myeloid leukemia

doi:10.1038/ncponc0144 | Full Text | PDF (57K)

Depression and anxiety among breast cancer patients

doi:10.1038/ncponc0142 | Full Text | PDF (55K)

Mutation screening in colorectal cancer

doi:10.1038/ncponc0145 | Full Text | PDF (61K)

Does sunlight reduce the risk of malignant lymphoma?

doi:10.1038/ncponc0146 | Full Text | PDF (55K)

Differential gene expression in androgen-independent prostate tumors

doi:10.1038/ncponc0147 | Full Text | PDF (63K)

Mechanism of drug resistance in non-small-cell lung cancer

doi:10.1038/ncponc0148 | Full Text | PDF (57K)

Long-term follow-up of a smoking cessation intervention

doi:10.1038/ncponc0149 | Full Text | PDF (64K)

Whole-body CT screening: is it cost-effective?

doi:10.1038/ncponc0130 | Full Text | PDF (61K)

Zinc deficiency increases esophageal cancer risk

doi:10.1038/ncponc0150 | Full Text | PDF (55K)

Risk of venous thrombosis among cancer patients

doi:10.1038/ncpcardio0165 | Full Text | PDF (55K)

CD24 expression predicts disease progression in prostate cancer

doi:10.1038/ncpuro0141 | Full Text | PDF (55K)

Re-induction of hormonal sensitivity in hormone-refractory prostate cancer—fact or fiction?

William R Berry

doi:10.1038/ncponc0136 | Full Text | PDF (70K)

What is the risk of second malignant neoplasms after childhood cancer?

Smita Bhatia

doi:10.1038/ncponc0129 | Full Text | PDF (69K)

Can combination salvage therapy for invasive aspergillosis improve patient outcome?

Raoul Herbrecht and Shanti Natarajan-Amé

doi:10.1038/ncponc0128 | Full Text | PDF (73K)

Does secondary surgical cytoreduction improve survival in women with advanced ovarian cancer?

Adnan Munkarah

doi:10.1038/ncponc0131 | Full Text | PDF (70K)

Which should be added to cisplatin for advanced non-small-cell lung cancer—vinorelbine or gemcitabine?

Giorgio V Scagliotti

doi:10.1038/ncponc0137 | Full Text | PDF (72K)

Can outpatient interleukin-2 and interferon replace high-dose interleukin-2 for metastatic renal cell carcinoma?

Johannes Vieweg

doi:10.1038/ncponc0134 | Full Text | PDF (72K)

Does addition of temozolomide to whole brain radiotherapy improve outcome in patients with brain metastases?

Sara C Erridge and Anna Gregor

doi:10.1038/ncponc0138 | Full Text | PDF (77K)

Mechanisms of Disease: inflammatory mediators and cancer prevention

Jason R Mann, Michael G Backlund and Raymond N DuBois

doi:10.1038/ncponc0140 | Full Text | PDF (337K)

Intensity-modulated radiation therapy for the treatment of pediatric cancer patients

Agata Rembielak and Tony Choon Seng Woo

doi:10.1038/ncponc0139 | Full Text | PDF (111K)